InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+16.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by BISHOP JOHN L, Director. Officer active across 2 companies, notably Veracyte, INC.. Cumulatively, 11 reports have been recorded. History available since 8 June 2021. The latest transaction was filed on 17 July 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
10,000 shares@ US$6.37100.0% of flowCommon StockSEC:0001384101-23-000132:0
9,674 shares0Common StockSEC:0001384101-23-000126:0
14,731 shares0Common StockSEC:0001384101-22-000095:0
8,720 shares0Common StockSEC:0001384101-21-000110:0
8,720 shares0Common StockSEC:0001384101-21-000110
1,219 sharesCommon StockSEC:0001209191-16-095076:0
534 sharesCommon StockSEC:0001209191-16-095076:1
1,219 sharesCommon StockSEC:0001209191-16-093450:0
534 sharesCommon StockSEC:0001209191-16-093450:1
1,062 sharesCommon StockSEC:0001209191-16-093450:2
437 sharesCommon StockSEC:0001209191-16-093450:3
11 of 11 declarations
About BISHOP JOHN L
John L. Bishop is a Director at Veracyte, Inc., a company specializing in diagnostic solutions. In this role, he contributes to the governance of the company and the development of its strategy. Bishop brings expertise in biotechnology and research, allowing him to play a key role in performance evaluation and company direction. His commitment to innovation and improving healthcare is central to his mission.
